Double Filtration Plasmapheresis Combined With Chemotherapy

Screening and Therapeutic Monitoring of Multiple Myeloma by MALDI-TOF MS Analysis

NCT05686447 ·Status: RECRUITING

Study of the Safety and Efficacy of an Investigational Drug in Adult Patients With Multiple Myeloma

NCT00036140 ·Status: COMPLETED ·Phase: PHASE1

Rituximab and Cyclophosphamide in Treating Patients With High Risk, Refractory, or Relapsed Multiple Myeloma

NCT00258206 ·Status: COMPLETED ·Phase: PHASE2

Helical Tomotherapy in Multiple Myeloma

NCT05970198 ·Status: RECRUITING ·Phase: NA

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

NCT04221178 ·Status: ACTIVE_NOT_RECRUITING

Study of Fluphenazine in Relapsed or Relapsed-and-Refractory Multiple Myeloma

NCT00821301 ·Status: UNKNOWN ·Phase: PHASE1

Somatostatin Receptors Imaging in Relapsing and Refractory Multiple Myeloma Patients

NCT04379817 ·Status: COMPLETED ·Phase: PHASE2

Combination of Bortezomib, Fludarabine and Cyclophosphamide Treat Recurrent Mantle Cell Lymphoma

NCT01322776 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study to Determine the Efficacy, Safety and Pharmacokinetics of GMI-1271 as Adjunct to Standard of Care for the Treatment of Multiple Myeloma

NCT02811822 ·Status: COMPLETED ·Phase: PHASE1

High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment

NCT01679041 ·Status: TERMINATED ·Phase: PHASE2

Vaccination With Peptides From Anti-apoptotic Proteins in Relapsed Multiple Myeloma

NCT01272466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma

NCT06126237 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Panobinostat and Carfilzomib in Treating Participants With Relapsed or Refractory Multiple Myeloma

NCT01301807 ·Status: COMPLETED ·Phase: PHASE1

Primary Multiple Myeloma Who Achieved MRD Negativity After Induction Therapy, ASCT or Not

NCT06463717 ·Status: RECRUITING

Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients

NCT06457464 ·Status: NOT_YET_RECRUITING

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

NCT01109407 ·Status: TERMINATED

Therapeutic Research in Multiple Myeloma

NCT00572338 ·Status: COMPLETED

Effects of Early Palliative Care Integration on Patients With Newly Diagnosed Multiple Myeloma

NCT04248244 ·Status: COMPLETED ·Phase: NA

Study to Evaluate the Safety and Efficacy of Daratumumab and Carfilzomib-based Induction/Consolidation/Maintenance Therapy in Transplant-eligible, Ultra High-risk, Newly Diagnosed Multiple Myeloma

NCT06140966 ·Status: RECRUITING ·Phase: PHASE2

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

NCT00165347 ·Status: COMPLETED ·Phase: PHASE2

This is an Open-label, Single Arm Study to Evaluate the Safety and Tolerability of Treatment With CT0591CP in Patients With Relapsed and/or Refractory Multiple Myeloma.

NCT05486975 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Leflunomide for the Treatment of High-Risk Smoldering Multiple Myeloma

NCT04370483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Conversion to Carfilzomib Therapy in Bortezomib Intolerant Newly Diagnosed Multiple Myeloma(NDMM) Patients

NCT06682156 ·Status: RECRUITING

Discontinuation Study

NCT05866757 ·Status: RECRUITING ·Phase: NA

Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma

NCT03127761 ·Status: RECRUITING